awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35759606-8AF3D31F-B0CD-4C86-A36C-0BD21547F48D
Q35759606-8AF3D31F-B0CD-4C86-A36C-0BD21547F48D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35759606-8AF3D31F-B0CD-4C86-A36C-0BD21547F48D
Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications
P2860
Q35759606-8AF3D31F-B0CD-4C86-A36C-0BD21547F48D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35759606-8AF3D31F-B0CD-4C86-A36C-0BD21547F48D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ec45109a6ddf2fdd6ccb9631234e8eead55952db
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.